Reversal agents for oral anticoagulants

Nurse Pract. 2017 Nov 16;42(11):8-14. doi: 10.1097/01.NPR.0000525714.86663.bd.

Abstract

For more than half a century, warfarin, a vitamin K antagonist, has been the anticoagulant of choice. However, direct oral anticoagulants are rapidly gaining in popularity, which poses the need for efficacious reversal agents. This review article summarizes the strategies and agents used to reverse oral anticoagulants.

Publication types

  • Review

MeSH terms

  • Administration, Oral
  • Anticoagulants / administration & dosage*
  • Clinical Trials, Phase III as Topic
  • Dabigatran / antagonists & inhibitors*
  • Humans
  • Pyrazoles / antagonists & inhibitors*
  • Pyridines / antagonists & inhibitors*
  • Pyridones / antagonists & inhibitors*
  • Rivaroxaban / antagonists & inhibitors*
  • Thiazoles / antagonists & inhibitors*
  • Warfarin / antagonists & inhibitors*

Substances

  • Anticoagulants
  • Pyrazoles
  • Pyridines
  • Pyridones
  • Thiazoles
  • apixaban
  • Warfarin
  • Rivaroxaban
  • Dabigatran
  • edoxaban